This round table aims to foster a rich, multi-perspective dialogue on the evolving role of artificial intelligence (AI) in public health. By bringing together key voices from across the Spanish health ecosystem - including industry leadership, clinical practice, technological innovation, and AI expertise - the discussion seeks to explore both the current applications and future potential of AI in improving population health outcomes.
The session will provide a platform to examine the opportunities, challenges and responsibilities inherent in integrating AI into public health systems. Particular attention will be given to critical dimensions such as regulatory frameworks, ethical considerations, implementation strategies and real-world impact. Through the convergence of these diverse perspectives, the event aspires to generate practical insights and forward-looking guidance that can inform sustainable, equitable and effective adoption of AI in public health.
Who should attend?
Physicians, pharmaceutical industry workers, PhD students and anyone working in the interface between academia and hospital campus.
Speakers
-
Carlos Molina (Coordinator of the Stroke Unit at the Vall d’Hebron University Hospital)
-
Giuseppe Chiericatti (General Director at Chiesi Spain and Portugal)
-
Pep Martorell (Partner at InvivoAI)
-
Josefina Martín (Chief Executive Officer at Helix AI)
Schedule
-
17:00 – 17:10. Institutional Remarks by Joan Compte (Director of Podcast at Nucleate Spain and MSL at Chiesi Spain).
-
17:10 – 17:20. How society envisages AI as a health modulator; presentation by Pep Martorell
-
17:20 – 18:00. Assessing the readiness of key health ecosystem stakeholders' systems for implementing AI
-
18:00 – 18:10. AI in public health: UMBRELLA project as current paradigm; presentation by Carlos Molina
-
18:10 – 18:50. AI in the public health system: present and future perspectives
-
18:50 – 19:00. Concluding remarks
Partner
- Chiesi Spain & Portugal
About Nucleate
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation, removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!:
